(Q71236398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

editorial

0 references

title

Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

1 reference

M Markman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

443-444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01187154

17 October 2019

exact match

0 references

cites work

Advanced ovarian cancer. Carboplatin versus cisplatin

1 reference

12 December 2020

Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer

1 reference

12 December 2020

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

1 reference

12 December 2020

Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma

1 reference

12 December 2020

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

1 reference

12 December 2020

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

12 December 2020

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01187154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698742%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference